Positive New Data on Corcym’s Perceval Plus Sutureless Aortic Heart Valve Encompasses up to 7-Year Follow-up

Contributed by: Business Wire

Logo

Tags

Medical Devices

Health

Hospitals

Surgery

Clinical Trials

Cardiology

Corcym

More Like This

PR Newswire associated0

Cardiovalve Submits CE File for Approval Following Successful TARGET Study Completion

The 1-Year Follow-up Results of LuX-Valve Plus were Officially Released at TCT 2024

Business Wire embedded0

CroíValve Announces Funding from Horizon Europe EIC Accelerator

Cardiovalve Completes TARGET Study Enrollment for CE Registration Study for Tricuspid Valve Replacement

Carillon Mitral Contour System®

Cardiac Dimensions® Announces Three Major Publications Demonstrating Long-Term Durability, Real-World Performance, and Broad Patient Benefit of the Carillon Mitral Contour System®

Business Wire embedded0

CroíValve Announces $16 Million Equity Financing to Fund US Early Feasibility Study of Novel Transcatheter Tricuspid Device

EuroPCR: Medtronic Evolut™ TAVR Platform Demonstrates Improved Quality of Life for Women with Severe Aortic Stenosis

The MITRIS RESILIA valve is made with innovative tissue technology RESILIA allowing the valve to potentially last longer than conventional bioprosthetic valves.* (Photo: Business Wire)

Edwards MITRIS RESILIA Valve Receives CE Mark for Mitral Replacement Surgeries